Close Menu

The Times Online reports that a new company based in Boston, Foundation Medicine, has raised $25 million to develop a "one-stop-shop service for genomic diagnosis of cancer." The company's founders include Broad Institute director Eric Lander as well as Levi Garraway, Matthew Meyerson, and Todd Golub of the Dana Farber Cancer Institute and Harvard Medical School, the paper reports.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.